Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.

about

Comments on: Lyubarova, R. and Gosmanova, E.O. Mineralocorticoid Receptor Blockade in End-Stage Renal Disease. Current Hypertension Reports, 2017. 19(5).

P2860

Q52836149-5A28915F-AB7E-40BD-A1F7-3CB097809742

P2860

Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.

Item

http://www.wikidata.org/entity/Q38815486

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.

@en

type

Item

label

Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.

@en

prefLabel

Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.

@en

P1476

Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.

@en

P2093

Elvira O Gosmanova

http://www.w3.org/2001/XMLSchema#string

Radmila Lyubarova

http://www.w3.org/2001/XMLSchema#string

P2860

Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor

The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis.

Long-term effects of spironolactone in peritoneal dialysis patients

Assessment and management of hypertension in patients on dialysis.

A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Enhanced large intestinal potassium permeability in end-stage renal disease.

Aldosterone and mortality in hemodialysis patients: role of volume overload.

P2888

s11906-017-0737-y

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11906-017-0737-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085075299

http://www.w3.org/2001/XMLSchema#string

P698

28451852

http://www.w3.org/2001/XMLSchema#string

Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.

about

P2860

P2860

Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698